Skip to main content
. 2018 Aug 30;14:257. doi: 10.1186/s12917-018-1590-1

Table 1.

Antimicrobials used in the study and the tested concentration ranges

Antimicrobialsa Abbreviation Breakpoints (μg/mL) Concentration ranges (μg/mL)
Sb I R
Nalidixic acid NAL 16 -c 32 2–128
Ciprofloxacin CIP 0.06 0.12–0.5 1 0.12–16
Enrofloxacin ENR 0.25 0.5–1 2 0.12–64
Neomycin NEO 16 2–32
Gentamicin GEN 4 8 16 1–64
Streptomycin STR 32 64 2–128
Tetracycline TET 4 8 16 2–128
Azithromycin AZM 16 32 0.25–64
Amoxicillin/clavulanic acid AMC 8/4 16/8 32/16 2/1–64/32
Cefoxitin FOX 8 16 32 1–32
Ceftiofur XNL 2 4 8 0.5–8
Ampicillin AMP 8 16 32 2–32
Trimethoprim/sulfamethoxazole SXT 2/38 4/76 0.12/2.38–4/76
Colistin COL 2 4 2–32
Florfenicol FFN 32 2–64
Chloramphenicol CHL 8 16 32 2–64
Tigecycline TIG 2 4 8 0.12–32
Fosfomycin FOS 64 128 256 0.25–256

aSorted based on category of antimicrobials

bS, sensitivity; I, intermediate resistance; R, resistance

c-, no standard breakpoint value in related references